CLASS II Device recall · Reported 18 Mar 2015 · FDA Enforcement Report

Siemens Healthcare Caps for capillary 100 uL recalled

Siemens Healthcare Diagnostics is recalling Siemens Healthcare Caps for capillary 100 uL , Package count 200 For use with blood, distributed nationwide in the US. The recall was initiated on 22 Jan 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lot codes
Quantity recalled10741

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1256-2015
FDA event ID
70287
Recalling firm
Siemens Healthcare Diagnostics, Norwood, MA
Classification
Class II
Status
Terminated
Recall initiated
22 Jan 2015
FDA classified
6 Mar 2015
Reported
18 Mar 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

22 Jan 2015Recall initiated by company
6 Mar 2015Classified by FDA+43 days
18 Mar 2015Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Capillary Caps for RAPIDLyte Multicap and Multicap-S Blood Collection Capillaries may not attach and result in breakage of the glass capillary

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Siemens Healthcare Caps for capillary 100 uL , Package count 200 For use with blood collection Multicap glass and Multicap-S plastic capillaries SMN: 10311053 Legacy Part number: 478601

Where it was distributed

Worldwide Distribution. US Nationwide, Australia, Austria, Belgium, Bosnia, Herzegovina, Canada, Colombia, Croatia, Curacao, Czech Republic, Estonia, Finland, France, Georgia, Germany, Great Britain, Hong Kong, Ireland, Italy, Japan, Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates.

Nationwide Georgia

Questions about this recall

Why was it recalled?

Capillary Caps for RAPIDLyte Multicap and Multicap-S Blood Collection Capillaries may not attach and result in breakage of the glass capillary

Which lots are affected?

All lot codes

Where was it sold?

Worldwide Distribution. US Nationwide, Australia, Austria, Belgium, Bosnia, Herzegovina, Canada, Colombia, Croatia, Curacao, Czech Republic, Estonia, Finland, France, Georgia, Germany, Great Britain, Hong Kong, Ireland, Italy, Japan, Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 70287

This product is part of a recall event; the main page for the event is Siemens Healthcare Caps for capillary 140/175 uL recalled.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Syringes & Needles recalls

All 1,060